Wheat right for Proteome
Thursday, 03 July, 2008
Sydney's Proteome Systems [ASX: PXL] has sold an exclusive license for its DiagnostIQ test device to Bayer CropScience.
Under the agreement Bayer and Proteome will also collaborate to produce new products based on the technology.
Bayer will own the commercialisation rights for the products, but will pay PXL product developments and license fees as well on royalties on each sale.
Bayer and Proteome have already collaborated to produce WheatRite, a quality assurance test that can be completed in three minutes.
WheatRite will be launched this year, and is initially to be sold in Canada, with expansion to other markets including Australia to occur later.
Indigenous-led initiative to resurrect the South Island Giant Moa
New Zealand's Ngāi Tahu Research Centre has partnered with Colossal Biosciences and Sir Peter...
Abnormal brain protein targeted in Parkinson's study
Researchers have identified a new brain protein involved in the development of Parkinson's...
Epilepsy disease model treated in a laboratory dish
A research team has used an epilepsy-like disease model in a laboratory dish to demonstrate that...
